Guido Stoll Selected Research

Interleukin-1beta (Interleukin 1 beta)

1/2006	Spatiotemporal pattern of neuroinflammation after impact-acceleration closed head injury in the rat.
1/2002	Detrimental and beneficial effects of injury-induced inflammation and cytokine expression in the nervous system.
1/2002	Interleukin-18 expression after focal ischemia of the rat brain: association with the late-stage inflammatory response.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guido Stoll Research Topics

Disease

57	Stroke (Strokes) 04/2024 - 03/2006
30	Ischemic Stroke 04/2024 - 05/2007
28	Thrombosis (Thrombus) 04/2023 - 11/2005
25	Infarction (Infarctions) 11/2023 - 01/2002
21	Inflammation (Inflammations) 04/2023 - 01/2002
18	Brain Ischemia (Cerebral Ischemia) 12/2023 - 01/2002
16	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 08/2022 - 01/2002
10	Hemorrhage 04/2024 - 03/2006
8	Neuroinflammatory Diseases 01/2023 - 01/2007
7	Reperfusion Injury 11/2023 - 05/2015
6	Ischemia 11/2023 - 01/2002
6	Cerebral Infarction 05/2022 - 11/2003
6	Brain Infarction 08/2021 - 04/2008
6	Wallerian Degeneration 03/2008 - 01/2002
4	Hypoxia (Hypoxemia) 12/2023 - 04/2011
4	Cognitive Dysfunction 01/2023 - 01/2018
4	Multiple Sclerosis 01/2019 - 09/2008
4	Peripheral Nerve Injuries 07/2012 - 11/2003
4	Edema (Dropsy) 04/2011 - 01/2009
4	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 02/2010 - 01/2007
4	Demyelinating Diseases (Demyelinating Disease) 09/2008 - 10/2003
3	Brain Edema (Cerebral Edema) 04/2011 - 01/2009
2	Heart Failure 10/2022 - 01/2022
2	Nervous System Diseases (Neurological Disorders) 10/2022 - 02/2009
2	Atrophy 01/2022 - 01/2018
2	Myasthenia Gravis 10/2019 - 07/2002
2	Cerebral Hemorrhage 01/2017 - 12/2015
2	Myocardial Infarction 07/2012 - 04/2010
2	Nerve Degeneration 06/2010 - 03/2005
2	Neuralgia (Stump Neuralgia) 03/2010 - 08/2006
2	Experimental Autoimmune Neuritis 03/2008 - 01/2006

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2004
10	Contrast MediaIBA 01/2013 - 03/2005
9	Biomarkers (Surrogate Marker)IBA 04/2024 - 04/2011
9	Glycoproteins (Glycoprotein)IBA 02/2021 - 04/2009
9	CytokinesIBA 05/2019 - 01/2002
9	Factor XII (Hageman Factor)IBA 01/2019 - 03/2006
8	ferric oxide (iron oxide)IBA 01/2011 - 11/2003
7	von Willebrand FactorIBA 01/2014 - 04/2009
7	gadofluorine MIBA 11/2009 - 03/2005
6	GadoliniumIBA 01/2019 - 03/2005
5	AntigensIBA 02/2021 - 05/2010
5	KininsIBA 11/2012 - 01/2009
5	Messenger RNA (mRNA)IBA 01/2007 - 01/2002
4	Glial Fibrillary Acidic ProteinIBA 02/2024 - 01/2022
4	InflammasomesIBA 01/2023 - 01/2021
4	Platelet Membrane GlycoproteinsIBA 08/2022 - 12/2015
4	ChemokinesIBA 01/2022 - 08/2006
4	CalciumIBA 11/2019 - 07/2008
4	LigandsIBA 01/2019 - 04/2009
4	Bradykinin Receptors (Bradykinin Receptor)IBA 03/2011 - 05/2008
3	Oxygen (Dioxygen)IBA 12/2023 - 01/2009
3	FibrinIBA 04/2023 - 03/2006
3	EnzymesIBA 06/2022 - 06/2010
3	Tissue Plasminogen Activator (Alteplase)FDA Link 03/2022 - 10/2018
3	Immunoglobulin G (IgG)IBA 03/2021 - 03/2015
3	AntibodiesIBA 10/2019 - 06/2013
3	Collagen ReceptorsIBA 01/2016 - 10/2010
3	triphenyltetrazoliumIBA 12/2015 - 05/2007
3	IronIBA 06/2010 - 06/2005
3	Interleukin-18 (Interleukin 18)IBA 01/2010 - 01/2002
3	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2009 - 01/2002
3	Interleukin-1beta (Interleukin 1 beta)IBA 01/2006 - 01/2002
2	EndoglinIBA 11/2023 - 06/2022
2	Thrombin FDA Link 04/2023 - 07/2010
2	pro-brain natriuretic peptide (1-76)IBA 10/2022 - 01/2022
2	Calcium Channels (Calcium Channel)IBA 08/2022 - 11/2019
2	Therapeutic UsesIBA 08/2022 - 02/2021
2	HMGB1 Protein (HMG1)IBA 10/2021 - 08/2021
2	adhesion receptorIBA 02/2021 - 04/2009
2	Caspase 1 (ICE Protease)IBA 01/2021 - 01/2002
2	Glucose (Dextrose)FDA LinkGeneric 11/2019 - 04/2011
2	CollagenIBA 04/2019 - 10/2010
2	Factor XIIa (Coagulation Factor XIIa)IBA 01/2016 - 01/2016
2	LipidsIBA 09/2013 - 07/2006
2	CoagulantsIBA 07/2013 - 09/2011
2	FluorocarbonsIBA 07/2012 - 01/2011
2	von Willebrand factor receptor (VWF receptor)IBA 09/2011 - 10/2010
2	Immunoglobulin Fab FragmentsIBA 04/2011 - 05/2007
2	Platelet Glycoprotein GPIb-IX Complex (Glycoprotein Ib)IBA 04/2011 - 05/2007
2	ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA 06/2010 - 06/2005
2	Myelin-Oligodendrocyte GlycoproteinIBA 02/2010 - 09/2008
2	Interleukin-1 (Interleukin 1)IBA 01/2010 - 01/2002
2	Gadolinium DTPA (Magnevist)FDA Link 11/2009 - 03/2008
2	Rose BengalIBA 04/2008 - 05/2002
2	Coloring Agents (Dyes)IBA 04/2008 - 05/2002
2	Peptide Hydrolases (Proteases)FDA Link 04/2008 - 03/2006
2	Monoclonal AntibodiesIBA 05/2007 - 01/2006
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2007 - 01/2004
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2006 - 01/2002
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2006 - 01/2002
1	Matrix Metalloproteinases (MMPs)IBA 04/2024
1	PotassiumIBA 12/2023
1	SodiumIBA 12/2023
1	SynucleinsIBA 11/2023
1	CationsIBA 01/2023

Therapy/Procedure

16	Thrombectomy 04/2024 - 10/2018
7	Therapeutics 01/2024 - 06/2010
2	Microelectrodes 08/2019 - 05/2019
1	Treatment Delay 01/2023